Anaxsys secures funding to market respiratory system

The investors that participated in the funding include South East Growth Fund, Early Advantage Partnership and a number of business angels. Anaxsys has received £5.7m of funding to date, including £700,000 in grants.

Having consulted and collaborated with clinicians and other healthcare professionals, the engineers at Anaxsys identified that there was an unmet clinical need for respiratory rate monitoring, particularly in perioperative environments.

To address that market need, the company has developed a continuous respiratory rate counter called the respiR8 that provides an early indication of patient deterioration. Clinical trials and studies of the device have already confirmed its effectiveness and commercial potential with healthcare professionals.

The system consists of a disposable mask that contains an inexpensive sensor, a computer system and a monitor that provides a digital display of the respiratory rate. A second display screen demonstrates the trend of respiratory rate over the monitoring period. Any significant change in respiratory rate trips an alarm, allowing the healthcare professionals to make an immediate intervention.